Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus

Blood

Volumn 92, Issue 4, 1998, Pages 1317-1323

  Bessudo, Alberto ^b   Rassenti, Laura ^b   Havlir, Diane ^b   Richman, Douglas ^b   Feigal, Ellen ^b   Kipps, Thomas J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN M; SUPERANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGLOBULIN GENE; IMMUNOREGULATION; PRIORITY JOURNAL;

EID: 0032529327     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1317     Document Type: Article

References (45)

1. Serraino D, Salamina G, Franceschi S, Dubois D, La Vecchia C, Brunet JB, Ancelle-Park RA: The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region. Br J Cancer 66:912, 1992
2. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, Ziegler J, Volberding PA: AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 261:719, 1989
3. Cremer KJ, Spring SB, Gruber J: Role of human immunodeficiency virus type 1 and other viruses in malignancies associated with acquired immunodeficiency disease syndrome. J Natl Cancer Inst 82:1016, 1990
4. Astrin SM, Laurence J: Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes. Ann N Y Acad Sci 651:422, 1992
5. Karp JE, Broder S: The pathogenesis of AIDS lymphomas: A foundation for addressing the challenges of therapy and prevention. Leuk Lymphoma 8:167, 1992
6. Levine AM, Liebman HA: The acquired immunodeficiency syndrome (AIDS), in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology, New York, NY, McGraw-Hill, 1995, p 975
7. Bessudo A, Cherepakhin V, Johnson TA, Rassenti LZ, Feigal E, Kipps TJ: Favored use of immunoglobulin Vh4 genes in AIDS-associated B-cell lymphoma. Blood 88:252, 1996
8. Przybylski GK, Goldman J, Ng VL, McGrath MS, Herndier BG, Schenkein DP, Monroe JG, Silberstein LE: Evidence for early B-cell activation preceding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 88: 4620, 1996
9. Eclache V, Magnac C, Pritsch O, Delecluse HJ, Davi F, Raphael M, Dighiero G: Complete nucleotide sequence of Ig V genes in three cases of Burkitt lymphoma associated with AIDS. Leuk Lymphoma 20:281, 1996
10. H clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest [published erratum appears in Blood 1991 Oct 1:78(7): 1899]. Blood 78:175, 1991
11. H1 gene family expression in peripheral B cell IgM, IgD and IgG during HIV infection. Eur J Immunol 25:1524, 1995
12. H segments with different hypervariable loops. J Mol Biol 227:776, 1992
13. Walter MA, Surti U, Hofker MH, Cox DW: The physical organization of the human immunoglobulin heavy chain gene complex. EMBO J 9:3303, 1990
14. Pascual V, Capra JD: Human immunoglobulin heavy-chain variable region genes: organization, polymorphism, and expression. Adv Immunol 49:1, 1991
15. K repertoire revealed by in situ hybridization. Mol Immunol 27:935, 1990
16. H repertoire. Immunol Today 16:237, 1995
17. Nunez C, Nishimoto N, Gartland GL, Billips LG, Burrows PD, Kubagawa H, Cooper MD: B cells are generated throughout life in humans. J Immunol 156:866, 1996
18. Rassenti LZ, Kohsaka H, Kipps TJ: Analysis of immunoglobulin VH gene repertoire by an anchored PCR-ELISA. Ann N Y Acad Sci 764:463, 1995
19. Kohsaka H, Carson DA, Rassenti LZ, Oilier WE, Chen PP, Kipps TJ. Miyasaka N: The human immunoglobulin V(H) gene repertoire is genetically controlled and unaltered by chronic autoimmune stimulation. J Clin Invest 98:2794, 1996
20. Rassenti LZ, Kipps TJ: Lack of Allelic Exclusion in B cell chronic lymphocytic leukemia. J Exp Med 185:1435, 1997
21. H7 gene family. Eur J Immunol 22:241, 1992
22. H gene use in peripheral blood B cells. Blood 80:252a, 1992 (abstr)
23. Huang C, Stewart AK, Schwartz RS, Stollar BD: Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest 89:1331, 1992
24. Huang C, Stollar BD: A majority of Ig H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies. J Immunol 151:5290, 1993
25. H3 (D12 idiotope) B cells in vivo. J Acquir Immune Defic Syndr 7:641, 1994
26. Goodglick L, Braun J: Revenge of the microbes. Superantigens of the T and B cell lineage. Am J Pathol 144:623, 1994
27. Domiati-Saad R, Lipsky PE: B cell superantigens: Potential modifiers of the normal human B cell repertoire. Int Rev Immunol 14:309, 1997
28. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 179:873, 1994
29. H3 family antibodies bind domain D of staphylococcal protein A. J Immunol 154:6437, 1995
30. H4-expressing B cells from apoptosis. J Immunol 156:3608, 1996
31. Hakoda M, Hayashimoto S, Yamanaka H, Terai C, Kamatani N, Kashiwazaki S: Molecular basis for the interaction between human IgM and staphylococcal protein A. Clin Immunol Immunopathol 72:394, 1994
32. H3 gene products: Natural ligands for HIV gp120. Science 261:1588, 1993
33. Shirai A, Cosentino M, Leitman-Klinman SF, Klinman DM: Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 89:561, 1992
34. H-gene putative somatic mutation analysis. Blood 83:1067, 1994
35. H gene use by HIV type 1-associated lymphoproliferations. AIDS Res Hum Retroviruses 13:135, 1997
36. Coffin JM: HIV viral dynamics. AIDS 10:575, 1996 (suppl 3)
37. Coffin JM: HIV pathogenesis. Lines drawn in epitope wars [news; comment]. Nature 375:534, 1995
38. Pennisi E, Cohen J: Eradicating HIV from a patient: Not just a dream? [news]. Science 272:1884, 1996
39. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 66:1354, 1992
40. Connor RI, Mohri H, Cao Y, Ho DD: Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 67:1772, 1993
41. Richman DD, Bozzette SA: The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 169:968, 1994
42. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185:621, 1997
43. O'Brien WA, Koyanagi Y, Namazie A, Zhao JQ, Diagne A, Idler K, Zack JA, Chen IS: HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348:69, 1990
44. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135, 1996
45. D'Souza MP, Harden VA: Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat Med 2:1293, 1996